FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jelle Wesseling

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Jarich W Spliethoff; Johanna W van Sandick; Jelle Wesseling; Michel W Wouters; Daniel J Evers; Benno H W Hendriks; Houke Klomp; Gerald W Lucassen; Rami Nachabe; Theo J M Ruers
Improved identification of peripheral lung tumors by using diffuse reflectance and fluorescence spectroscopy.
Daniel J Evers; Benno H W Hendriks; Gerald W Lucassen; Rami Nachabe; Hester S A Oldenburg; Emiel J Rutgers; Jos A van der Hage; Marie-Jeanne Vranken Peeters; Jelle Wesseling; Theo J M Ruers
Diffuse reflectance spectroscopy: towards clinical application in breast cancer.
D J Evers; B H W Hendriks; D Hompes; G W Lucassen; R Nachabé; Frits van Coevorden; Marie-Louise F Van Velthuysen; Jelle Wesseling; T J M Ruers
Optical sensing for tumor detection in the liver.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jelle Wesseling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jarich W Spliethoff; Johanna W van Sandick; Jelle Wesseling; Michel W Wouters; Daniel J Evers; Benno H W Hendriks; Houke Klomp; Gerald W Lucassen; Rami Nachabe; Theo J M Ruers
Improved identification of peripheral lung tumors by using diffuse reflectance and fluorescence spectroscopy.
Lung cancer (Amsterdam, Netherlands) 2013;80(2):165-71.
2013: Daniel J Evers; Benno H W Hendriks; Gerald W Lucassen; Rami Nachabe; Hester S A Oldenburg; Emiel J Rutgers; Jos A van der Hage; Marie-Jeanne Vranken Peeters; Jelle Wesseling; Theo J M Ruers
Diffuse reflectance spectroscopy: towards clinical application in breast cancer.
Breast cancer research and treatment 2013;137(1):155-65.
2013: D J Evers; B H W Hendriks; D Hompes; G W Lucassen; R Nachabé; Frits van Coevorden; Marie-Louise F Van Velthuysen; Jelle Wesseling; T J M Ruers
Optical sensing for tumor detection in the liver.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2013;39(1):68-75.
2012: M Donker; Claudette E Loo; E J Th Rutgers; Gabe S Sonke; M E Straver; Renato A Valdés Olmos; Jelle Wesseling; M-J T F D Vrancken Peeters
Radioguided occult lesion localisation (ROLL) in breast-conserving surgery after neoadjuvant chemotherapy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(12):1218-24.
2012: Esther H Lips; Chad Livasy; Claudette E Loo; Rita A Mukhtar; Sjoerd Rodenhuis; E Shelley Hwang; Gabe S Sonke; Laura J van't Veer; Marie-Jeanne T F D Vrancken-Peeters; Jelle Wesseling; Christina Yau; Donald A Berry; Lisa A Carey; Jorma J de Ronde; Laura J Esserman
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Breast cancer research and treatment 2012;136(1):35-43.
2012: Laurien D C Hoefnagel; S L Meijer; Cathy B Moelans; Iris D Nagtegaal; Joost Oudejans; Cornelis A Seldenrijk; Paul van der Valk; ELSKEN VAN DER WALL; Carla H van Gils; Henk-Jan van Slooten; Jelle Wesseling; Pieter Wesseling; Pieter J Westenend; Joost Bart; Paulus van Diest
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases.
Cancer 2012;118(20):4929-35.
2012: Annemarie C Schmitz; Maurice A A J van den Bosch; Jelle Wesseling; Tanja Alderliesten; Harry Bartelink; Maria Gertenbach; Claudette E Loo; Willem P Th M Mali; Kenneth E Pengel; Emiel J Th Rutgers; Kenneth G A Gilhuijs
Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;104(1):11-8.
2012: Eline E Deurloo; Claudette E Loo; Emiel J Th Rutgers; Jincey D Sriram; H Jelle Teertstra; Jelle Wesseling; Kenneth G A Gilhuijs
MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
European radiology 2012;22(7):1504-11.
2012: Sven Rottenberg; Philip C Schouten; Wendy Sol; Eline van der Burg; Marieke A Vollebergh; Jelle Wesseling; Lodewyk Wessels; Serge A L Zander; Bas de Hoon; Jorma de Ronde; Jean-Pierre Gillet; Michael M Gottesman; Joost Gribnau; Janneke E Jaspers; Jos Jonkers; Martijn Jonkers; Ariena Kersbergen; Sabine C Linn; Martin Lodén; Marina Pajic; Piet Borst
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.
Cancer research 2012;72(9):2350-61.
2012: Simon A Joosse; Kim I M Brandwijk; Peter Devilee; Frans B L Hogervorst; Senno Verhoef; Jelle Wesseling; petra nederlof
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Breast cancer research and treatment 2012;132(2):379-89.
2012: Tim J A Dekker; Gerrit K J Hooijer; Judith R Kroep; Sybren L Meijer; Wilma E Mesker; Ed Schuuring; Vincent T H B M Smit; Jos Bart; James E Boers; Susan Ter Borg; Joost van Gorp; Jelle Wesseling; Marc J van de Vijver
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach.
Breast cancer research : BCR 2012;14(3):R93.
2011: Hermien Hartog; Hugo M Horlings; Bas Kreike; H Marike Boezen; Marc J van de Vijver; Winette T A van der Graaf; Bert van der Vegt; Abderrahim Ajouaou; Geertruida H de Bock; Jelle Wesseling
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
Breast cancer research and treatment 2011;129(3):725-36.
2011: Ron H N van Schaik; Laura J van 't Veer; Martin van Vliet; Jelle Wesseling; John A Foekens; Marleen Kok; Jan Lindemans; Sabine C Linn; Marion E Meijer-Van Gelder; Caroline Seynaeve; Stefan Sleijfer; Paul N Span; Fred C G J Sweep; Marianne van Fessem; Hanneke van Laarhoven; Els M J J Berns
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients.
Pharmacogenomics 2011;12(8):1137-46.
2011: M A Vollebergh; Jelle Wesseling; L F A Wessels; S Cornelissen; M de Bruin; E G E de Vries; F E Froklage; M Hauptmann; M Holtkamp; E H Lips; petra nederlof; S Rodenhuis; Marjanka K Schmidt; J G Schrama; E H van Beers; Marc J van de Vijver; Harm van Tinteren; Sabine C Linn
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(7):1561-70.
2011: Patrick W B Derksen; Tanya M Braumuller; Eline van der Burg; Marten Hornsveld; Elly Mesman; Jelle Wesseling; Paul Krimpenfort; Jos Jonkers
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
Disease models & mechanisms 2011;4(3):347-58.
2011: Gábor Cserni; Isabel Amendoeira; Simonetta Bianchi; Ewa Chmielik; James Degaetano; Daniel Faverly; Paulo Figueiredo; Maria P Foschini; Dorthe Grabau; Jocelyne Jacquemier; Handan Kaya; Janina Kulka; Manuela Lacerda; Inta Liepniece-Karele; Jose Martinez Penuela; Cecily Quinn; Peter Regitnig; Angelika Reiner-Concin; Anna Sapino; Paulus van Diest; Zsuzsanna Varga; Vania Vezzosi; Jelle Wesseling; Vasiliki Zolota; Enrique Zozaya - Alvarez; Clive A Wells
Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions.
European journal of cancer (Oxford, England : 1990) 2011;47(6):887-94.
2011: Claudette E Loo; Marieke E Straver; Sjoerd Rodenhuis; Sara H Muller; Jelle Wesseling; Marie-Jeanne T F D Vrancken Peeters; Kenneth G A Gilhuijs
Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):660-6.
2011: Simon A Joosse; Kim I M Brandwijk; Lennart Mulder; Jelle Wesseling; Juliane Hannemann; petra nederlof
Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Genes, chromosomes & cancer 2011;50(2):71-81.
2011: Esther H Lips; petra nederlof; Anne M M Oonk; Suvi P Savola; Marieke A Vollebergh; Jelle Wesseling; Lodewyk F A Wessels; Alex L T Imholz; Nadja Laddach; Sjoerd Rodenhuis
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.
Breast cancer research : BCR 2011;13(5):R107.
2010: Lotte E Elshof; Emiel J Th Rutgers; Eline E Deurloo; Claudette E Loo; Jelle Wesseling; Kenneth E Pengel; Kenneth G A Gilhuijs
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results.
Breast cancer research and treatment 2010;124(3):707-15.
2010: M E Straver; E J Th Rutgers; Sjoerd Rodenhuis; Sabine C Linn; Claudette E Loo; Jelle Wesseling; Nicola S Russell; Hester S A Oldenburg; Ninja Antonini; M T F D Vrancken Peeters
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.
Annals of surgical oncology 2010;17(9):2411-8.
2010: Fiona M Blows; Kristy E Driver; Marjanka K Schmidt; Annegien Broeks; Flora E van Leeuwen; Jelle Wesseling; Maggie C Cheang; Karen Gelmon; Torsten O Nielsen; Carl Blomqvist; Päivi Heikkilä; Tuomas Heikkinen; Heli Nevanlinna; Lars A Akslen; Louis R Bégin; William D Foulkes; Fergus J Couch; Xianshu Wang; Vicky Cafourek; Janet E Olson; Laura Baglietto; Graham G Giles; Gianluca Severi; Catriona A McLean; Melissa C Southey; Emad Rakha; Andrew Green; Ian O Ellis; Mark E Sherman; Jolanta Lissowska; William F Anderson; Angela Cox; Simon S Cross; Malcolm W R Reed; Elena Provenzano; Sarah-Jane Dawson; Alison M Dunning; Manjeet Humphreys; Douglas F Easton; Montserrat García-Closas; Carlos Caldas; Paul D Pharoah; David Huntsman
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
PLoS medicine 2010;7(5):e1000279.
2010: Stella Mook; Michael Knauer; Jolien M Bueno-de-Mesquita; Valesca P Retel; Jelle Wesseling; Sabine C Linn; Laura J van't Veer; Emiel J Rutgers
Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Annals of surgical oncology 2010;17(5):1406-13.
2010: Jorma de Ronde; Lodewyk Wessels; Jelle Wesseling
Molecular subtyping of breast cancer: ready to use?
The lancet oncology 2010;11(4):306-7.
2010: Marieke E Straver; Claudette E Loo; Emiel J T Rutgers; Hester S A Oldenburg; Jelle Wesseling; Marie-Jeanne T F D Vrancken Peeters; Kenneth G A Gilhuijs
MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
Annals of surgery 2010;251(4):701-7.
2010: Bea J van der Vegt; Jelle Wesseling; Ruud M Pijnappel; Monique D Dorrius; Gerard J den Heeten; Marnix A J de Roos; Geertruida H de Bock
Aggressiveness of 'true' interval invasive ductal carcinomas of the breast in postmenopausal women.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(4):629-36.
2010: Tjeerd Aukema; E J Th Rutgers; Wouter V Vogel; H Jelle Teertstra; Hester S A Oldenburg; M T F D Vrancken Peeters; Jelle Wesseling; Nicola S Russell; Renato A Valdés Olmos
The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2010;36(4):387-92.
2010: Reinoutje Kaas; Senno Verhoef; Jelle Wesseling; Matti A Rookus; Hester S A Oldenburg; Marie-Jeanne Vrancken Peeters; Emiel J T Rutgers
Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Annals of surgery 2010;251(3):488-92.
2010: S Rodenhuis; I A M Mandjes; Jelle Wesseling; M J van de Vijver; M-J T D F Vrancken Peeters; G S Sonke; S C Linn
A simple system for grading the response of breast cancer to neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):481-7.
2010: Carolien van Deurzen; Gabor Cserni; Simonetta Bianchi; Vania Vezzosi; RICCARDO ARISIO; Jelle Wesseling; Martin Asslaber; Maria P Foschini; Anna Sapino; Isabella Castellano; Grace Callagy; Daniel Faverly; Maria-Dolores Martin-Martinez; Cecily Quinn; Isabel Amendoeira; Janina Kulka; Angelika Reiner-Concin; Alicia Cordoba; Cornelis A Seldenrijk; Paulus van Diest
Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):999-1004.
2010: Marieke E Straver; Annuska M Glas; Juliane Hannemann; Jelle Wesseling; Marc J van de Vijver; E J Th Rutgers; Marie-Jeanne T F D Vrancken Peeters; Harm van Tinteren; Laura J van't Veer; Sjoerd Rodenhuis
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Breast cancer research and treatment 2010;119(3):551-8.
2010: Jorma J de Ronde; Juliane Hannemann; Hans Halfwerk; Lennart Mulder; Marieke E Straver; Marie-Jeanne T F D Vrancken Peeters; Jelle Wesseling; Marc J van de Vijver; Lodewyk F A Wessels; Sjoerd Rodenhuis
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response.
Breast cancer research and treatment 2010;119(1):119-26.
2010: Jolien M Bueno-de-Mesquita; D S A Nuyten; Jelle Wesseling; Harm van Tinteren; Sabine C Linn; Marc J van de Vijver
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):40-7.
2009: Jolien M Bueno-de-Mesquita; Sabine C Linn; R Keijzer; Jelle Wesseling; Dimitry S A Nuyten; C van Krimpen; C Meijers; P W de Graaf; M M E M Bos; A A M Hart; E J Th Rutgers; Johannes L Peterse; H Halfwerk; R de Groot; A Pronk; Arno N Floore; Annuska M Glas; Laura J van't Veer; Marc J van de Vijver
Validation of 70-gene prognosis signature in node-negative breast cancer.
Breast cancer research and treatment 2009;117(3):483-95.
2009: M E Straver; E J Th Rutgers; Nicola S Russell; Hester S A Oldenburg; Sjoerd Rodenhuis; Jelle Wesseling; A Vincent; M T F D Vrancken Peeters
Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.
European journal of cancer (Oxford, England : 1990) 2009;45(13):2284-92.
2009: Bea J van der Vegt; Geertruida H de Bock; Joost Bart; Nick G Zwartjes; Jelle Wesseling
Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(7):879-86.
2009: Marieke E Straver; Emiel J T Rutgers; Hester S A Oldenburg; Jelle Wesseling; Sabine C Linn; Nicola S Russell; Marie-Jeanne T F D Vrancken Peeters
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy.
American journal of surgery 2009;198(1):46-50.
2009: K E Pengel; Claudette E Loo; H Jelle Teertstra; Sara H Muller; Jelle Wesseling; Johannes L Peterse; Harry Bartelink; E J Th Rutgers; K G A Gilhuijs
The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.
Breast cancer research and treatment 2009;116(1):161-9.
2009: Tjeerd Aukema; Nicola S Russell; Jelle Wesseling; E J Th Rutgers
Extensive soft tissue resection with autologous tissue closure for locally recurrent breast cancer: lasting local control and acceptable morbidity.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(5):469-74.
2009: Sabine C Linn; Jelle Wesseling
Molecular tests for breast-cancer diagnosis?
The lancet oncology 2009;10(4):314-5.
2009: Carlo Patriarca; Piergiuseppe Colombo; Angelo Pio Taronna; Jelle Wesseling; Giada Franchi; Francesca Guddo; Richard Naspro; Roberto Maria Macchi; Paolo Giunta; Marcello Di Pasquale; Michele Parente; Carmelo Arizzi; Massimo Roncalli; Biagio Campo
Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1).
International journal of surgical pathology 2009;17(2):99-106.
2009: B van der Vegt; G H de Bock; Harry Hollema; Jelle Wesseling
Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges.
Critical reviews in oncology/hematology 2009;70(1):1-11.
2009: Alina Vrieling; Dorien W Voskuil; Astrid J Bosma; Donné M Majoor; Jaap van Doorn; Annemieke Cats; Annekatrien C T M Depla; Robin Timmer; Ben J M Witteman; Jelle Wesseling; Ellen Kampman; Laura J van't Veer
Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2009;19(2):126-35.
2009: C Holm; Marleen Kok; R Michalides; R Fles; R H T Koornstra; Jelle Wesseling; M Hauptmann; J Neefjes; J L Peterse; O Stål; G Landberg; S C Linn
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
The Journal of pathology 2009;217(3):372-9.
2008: M E Straver; J C van Adrichem; E J Th Rutgers; S Rodenhuis; S C Linn; C E Loo; K G Gilhuijs; H S A Oldenburg; Jelle Wesseling; N S Russell; N Antonini; M T F D Vrancken Peeters
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Nederlands tijdschrift voor geneeskunde 2008;152(46):2519-25.
2008: Hugo M Horlings; Ryan Van Laar; Jan-Martijn Kerst; Helgi H Helgason; Jelle Wesseling; Jacobus J M van Der Hoeven; Marc O Warmoes; Arno Floore; Anke Witteveen; Jaana Lahti-Domenici; Annuska M Glas; Laura J Van't Veer; Daphne de Jong
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4435-41.
2008: Hermien Hartog; Winette T A van der Graaf; Jelle Wesseling; Eveline van der Veer; H Marike Boezen
Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples.
Clinical biochemistry 2008;41(7-8):636-9.
2007: Jolien M Bueno-de-Mesquita; Wim H van Harten; Valesca P Retel; Laura J van't Veer; Frits S A M van Dam; Kim Karsenberg; Kirsten F L Douma; Harm van Tinteren; Johannes L Peterse; Jelle Wesseling; Tin S Wu; Douwe Atsma; E J Th Rutgers; Guido Brink; Arno N Floore; Annuska M Glas; R M H Roumen; Frank E Bellot; Cees van Krimpen; Sjoerd Rodenhuis; Marc J van de Vijver; Sabine C Linn
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
The lancet oncology 2007;8(12):1079-87.
2007: Bea J van der Vegt; M A J De Roos; J L Peterse; Carlo Patriarca; J Hilkens; Geertruida H de Bock; Jelle Wesseling
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
Histopathology 2007;51(3):322-35.
2007: Hermien Hartog; Jelle Wesseling; H Marike Boezen; Winette T A van der Graaf
The insulin-like growth factor 1 receptor in cancer: old focus, new future.
European journal of cancer (Oxford, England : 1990) 2007;43(13):1895-904.
2007: M A J De Roos; Bea J van der Vegt; J L Peterse; Carlo Patriarca; Jolanda De Vries; Geertruida H de Bock; Jelle Wesseling
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
Histopathology 2007;51(2):227-38.
2007: M A J De Roos; Bea J van der Vegt; Jolanda De Vries; Jelle Wesseling; Geertruida H de Bock
Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.
Annals of surgical oncology 2007;14(7):2097-104.
2007: Jan J Koornstra; Jelle Wesseling; A E de Jong; H F A Vasen; Jan H Kleibeuker; E B Haagsma
Increased risk of colorectal neoplasia in asymptomatic liver-transplant recipients.
Gut 2007;56(6):892-3.
2007: M A J De Roos; Geertruida H de Bock; Jolanda De Vries; Bea J van der Vegt; Jelle Wesseling
p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
The Journal of surgical research 2007;140(1):109-14.
2007: M C Boelens; Anke Van den Berg; I Vogelzang; Jelle Wesseling; D S Postma; Wim Timens; H J M Groen
Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.
Journal of clinical pathology 2007;60(6):608-14.
2007: D M Heijink; Jan H Kleibeuker; Mathilde Jalving; Wytske Boersma-van Ek; Jan J Koornstra; Jelle Wesseling; Steven de Jong
Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(5):409-19.
2006: Mathilde Jalving; Jan J Koornstra; Jelle Wesseling; H Marike Boezen; Steven de Jong; Jan H Kleibeuker
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
Alimentary pharmacology & therapeutics 2006;24(9):1341-8.
2006: F Waanders; P van Hengel; A Krikke; Jelle Wesseling; P Nieboer
Sarcoidosis mimicking metastatic disease: a case report and review of the literature.
The Netherlands journal of medicine 2006;64(9):342-5.
2006: Mathilde Jalving; Steven de Jong; Jan J Koornstra; Wytske Boersma-van Ek; Nynke Zwart; Jelle Wesseling; Elisabeth G E de Vries; Jan H Kleibeuker
TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4350-6.
2006: André Zandvoort; Ymke M van der Geld; M R Jonker; Jacobien A Noordhoek; J T W M Vos; Jelle Wesseling; Henk Kauffman; Wim Timens; Dirkje S Postma
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;28(1):113-22.
2005: Henderik L van Westreenen; David C P Cobben; Pieter L Jager; Hendrik M van Dullemen; Jelle Wesseling; Philip H Elsinga; John T M Plukker
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):400-4.
2005: B Leegte; Annemarie H Van Der Hout; A M Deffenbaugh; M K Bakker; Inge M Mulder; A ten Berge; E P Leenders; Jelle Wesseling; Joanne A de Hullu; Nicoline Hoogerbrugge; M J L Ligtenberg; Audrey Ardern-Jones; Elizabeth Bancroft; Ashi Salmon; Julian Barwell; Rosalind Eeles; Jan C Oosterwijk
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
Journal of medical genetics 2005;42(3):e20.
2004: Bea J van der Vegt; M H E Doting; Pieter L Jager; Jelle Wesseling; Jolanda De Vries
Axillary recurrence after sentinel lymph node biopsy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2004;30(7):715-20.
2004: Rudy Komdeur; C Meijer; M Van Zweeden; Steven de Jong; Jelle Wesseling; Harald J Hoekstra; Winette T A van der Graaf
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells.
International journal of oncology 2004;25(3):677-84.
2004: Diana C J Spierings; Elisabeth G de Vries; Edo Vellenga; Fiona A J van den Heuvel; Jan J Koornstra; Jelle Wesseling; Harry Hollema; Steven de Jong
Tissue distribution of the death ligand TRAIL and its receptors.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2004;52(6):821-31.
2003: Carolien P Schröder; Marcel H J Ruiters; Steven de Jong; Anton T M G Tiebosch; Jelle Wesseling; Rense Veenstra; Jolanda De Vries; Harold J Hoekstra; Lou F M H De Leij; Elisabeth G E de Vries
Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
International journal of cancer. Journal international du cancer 2003;106(4):611-8.
1996: Jelle Wesseling; S W van der Valk; J Hilkens
A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.
Molecular biology of the cell 1996;7(4):565-77.
1996: H B Kwa; Jelle Wesseling; A H Verhoeven; nico van zandwijk; J Hilkens
Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
British journal of cancer 1996;73(4):439-46.
1995: J Van der Kaay; Jelle Wesseling; peter van haastert
Nucleus-associated phosphorylation of Ins(1,4,5)P3 to InsP6 in Dictyostelium.
The Biochemical journal 1995;312 ( Pt 3)():911-7.
1995: J Hilkens; Jelle Wesseling; H L Vos; J Storm; B Boer; S W van der Valk; M C Maas
Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas.
Biochemical Society transactions 1995;23(4):822-6.
1995: Jelle Wesseling; S W van der Valk; H L Vos; Arnoud Sonnenberg; J Hilkens
Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.
The Journal of cell biology 1995;129(1):255-65.
1995: J Hilkens; H L Vos; Jelle Wesseling; M Boer; J Storm; S van der Valk; Jero Calafat; Carlo Patriarca
Is episialin/MUC1 involved in breast cancer progression?
Cancer letters 1995;90(1):27-33.
1994: H Kemperman; Yvonne M Wijnands; Jelle Wesseling; CM Niessen; Arnoud Sonnenberg; Ed Roos
The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.
The Journal of cell biology 1994;127(6 Pt 2):2071-80.